Scandion Oncology’s rights issue registered with the Danish Business Authority – BTAs are converted to shares
Scandion Oncology A/S ("Scandion" or the "Company") has carried out a rights issue of approximately SEK 236 million. Today, on 6 January 2021, the share capital increase and updated articles of association have been registered with the Danish Business Authority.The last day of trading in paid subscribed shares (BTAs) is 12 January 2021. BTAs will be converted to shares on 18 January 2021 and the ISIN code for the BTAs will be merged with the permanent ISIN code on 18 January 2021. The newly issued shares are expected to be delivered to the shareholders’ securities accounts on 18 January